Protagenic Therapeutics Files 8-K
Ticker: PTIXW · Form: 8-K · Filed: May 21, 2025 · CIK: 1022899
| Field | Detail |
|---|---|
| Company | Protagenic Therapeutics, Inc.\New (PTIXW) |
| Form Type | 8-K |
| Filed Date | May 21, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, regulatory
Related Tickers: PTIX
TL;DR
Protagenic Therapeutics filed an 8-K on May 21, 2025, for an event on May 15, 2025.
AI Summary
Protagenic Therapeutics, Inc. filed an 8-K on May 21, 2025, reporting an event on May 15, 2025. The filing pertains to Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Atrinsic, Inc., is incorporated in Delaware and headquartered in New York.
Why It Matters
This 8-K filing indicates a regulatory disclosure event for Protagenic Therapeutics, Inc., potentially impacting investor understanding of recent company activities.
Risk Assessment
Risk Level: low — The filing is a standard 8-K current report, indicating routine disclosure rather than a significant negative event.
Key Players & Entities
- Protagenic Therapeutics, Inc. (company) — Filer
- May 15, 2025 (date) — Earliest Event Reported
- May 21, 2025 (date) — Filing Date
- Atrinsic, Inc. (company) — Former Company Name
- NEW YORK (location) — Business Address City
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing serves as a Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, covering Regulation FD Disclosure and Financial Statements and Exhibits.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported is May 15, 2025.
When was this 8-K form filed with the SEC?
This 8-K form was filed as of date May 21, 2025.
What was Protagenic Therapeutics, Inc. formerly known as?
Protagenic Therapeutics, Inc. was formerly known as Atrinsic, Inc.
Where is Protagenic Therapeutics, Inc. incorporated and what is its business address?
Protagenic Therapeutics, Inc. is incorporated in Delaware and its business address is 149 FIFTH AVENUE, SUITE 500, NEW YORK, NY 10010.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 21, 2025 regarding Protagenic Therapeutics, Inc.\new (PTIXW).